Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Saito (Sapporo, Japan), R. Takamiya (Tokyo, Japan), N. Fujitani (Sapporo, Japan), S. Ariki (Sapporo, Japan), K. Kuronuma (Sapporo, Japan), H. Chiba (Sapporo, Japan), M. Takahashi (Sapporo, Japan), H. Takahashi (Sapporo, Japan). Pulmonary Alveolar Microlithiasis ~ Epidemiology in Japan and Developing treatment strategies in a novel mouse model ~. 2145

Member's Comments

No comment yet.

Related content which might interest you: Miniaturization of the organ care system® into rat lungs for the establishment of ex-vivo therapy Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Establishment of the consecutive registration system for pulmonary alveolar proteinosis in Japan: Updated incidence, prevalence and surveillance for intractable cases Source: International Congress 2016 – Orphan diseases I Year: 2016 Pulmonary Alveolar Microlithiasis: From Diagnosis to Transplant: An Indian Experience Source: International Congress 2019 – Lung transplantation: from bench to bedside Year: 2019 Modeling human pulmonary inflammatory diseases and therapeutic responses in a microfluidic lung airway-on-a-chip Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Disease entities and microbiological results of 430 patients with non-CF bronchiectasis - Target for new diagnostics and therapies? Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Targeted lung denervation in the healthy sheep model - A potential treatment for COPD Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Late Breaking Abstract - Development of an animal model for group 3 Pulmonary Hypertension Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 Pulmonary alveolar proteinosis: iPS derived macrophages as in-vitro disease model and potential source for novel gene and cell therapies Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Multidisciplinary approach in management of extended and multifocal benign tracheal stenosis: Lessons learned Source: Annual Congress 2013 –Therapeutical bronchoscopy for treatment of airway disorders: laser, stents and more Year: 2013 A new Humanized Mouse Model for Idiopathic Pulmonary Fibrosis and Effects of Nintedanib Treatment Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias Year: 2018 Pulmonary tuberculosis and lung cancer: A complex interaction Source: International Congress 2016 – The best clinical approach to lung diseases Year: 2016 Treatment of pulmonary carcinoid: Are there new options? Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Digital Therapy in the treatment of asthma and COPD - Epidemiology of development and use of an emerging health technology in Respiratory Medicine Source: International Congress 2019 – M-health/e-health II Year: 2019 Evaluation of Idiopathic Pulmonary Fibrosis therapies, Pirfenidone and Nintedanib, in a Human Experimental Model of Fibrosis Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 Epoprostenol dosing by concomitant therapies in the PROSPECT registry Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Role of Pulmonary Rehabilitation (PR) on clinical care in patients with advance Interstitial Lung Diseases. Does it make any difference? Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care Year: 2021 Evolution of pulmonary function in European community respiratory health survey Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 The Italian Reference Center Database for Pulmonary Alveolar Proteinosis (PAP). Source: International Congress 2017 – Rare diseases Year: 2017 ASK1 promotes maladaptive remodeling in a rodent model of pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Intrapulmonary transplantation of macrophage progenitors as long-lasting therapy for hereditary pulmonary alveolar proteinosis Source: International Congress 2014 – Bronchoscopy in peripheral pulmonary lesions and diffuse lung diseases Year: 2014